Mindfulness and Yoga Therapy for Acute Pain in Sickle Cell Disease

Sponsor
University of Texas Southwestern Medical Center (Other)
Overall Status
Recruiting
CT.gov ID
NCT05572294
Collaborator
(none)
50
1
1
13.6
3.7

Study Details

Study Description

Brief Summary

Patients with sickle cell disease suffer from acute and chronic pain that diminishes their quality of life. The purpose of this study is to assess the feasibility and acceptability of mindfulness meditation, breathing exercises, and gentle yoga therapy as supportive measures for the management of acute vaso-occlusive pain crises in the inpatient setting.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Mindfulness meditation, breathing exercises (including incentive spirometry), and yoga therapy
N/A

Detailed Description

This is a prospective single arm study of mindfulness interventions for sickle cell patients admitted with an acute vaso-occlusive pain crisis. Patients will be accrued over a consecutive 12 week period. All genotypes of sickle cell disease will be eligible for enrollment.

After providing informed consent, the patients will have access to 4 videos on their hospital room television. The videos contain guided mindfulness meditation, breathing exercises (including the use of an incentive spirometer), and gentle yoga therapy that can be performed in the supine position from a hospital bed. Videos vary in length from 5-12 minutes. Participants will have the ability to watch the videos as many times as they choose. They may also turn off the video at any time.

The primary outcome is feasibility and acceptability of the intervention. We will record objective data on how many videos are watched by each participant, as well as the percentage of each video completed. We will obtain information about the participants' perception of the intervention through a post-intervention survey and interview.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Mindfulness and Yoga Therapy for Acute Pain in Sickle Cell Disease
Actual Study Start Date :
Nov 10, 2022
Anticipated Primary Completion Date :
Dec 30, 2023
Anticipated Study Completion Date :
Dec 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Mindfulness and Yoga Therapy

Participants will have access to video-guided mindfulness interventions.

Behavioral: Mindfulness meditation, breathing exercises (including incentive spirometry), and yoga therapy
Sickle cell patients admitted with a vaso-occlusive pain crisis over a consecutive 12-week period will be offered participation in the study. After providing informed consent, participants will have access to 4 videos containing guided mindfulness meditation, breathing exercises, and gentle yoga therapy. The videos are 5-12 minutes long and taught by a physical therapist who is also certified in yoga therapy. Participants may turn off the video at any time. Participants will have access to the videos for the duration of their hospitalization, and they may watch the videos as many times as they desire.

Outcome Measures

Primary Outcome Measures

  1. Feasibility of the intervention as measured by the proportion of sickle cell patients admitted over a consecutive 12 week time period who agree to participate in the study [12 weeks]

  2. Feasibility of the intervention as measured by the proportion of participants who accessed the mindfulness videos during their hospitalization [12 weeks]

  3. Acceptability of the intervention as measured by the proportion of participants who found the mindfulness practices enjoyable and/or helpful [at the time of hospital discharge, up to 6 months post-intervention]

    This data will be collected via a post-intervention survey and interview. The survey will contain simple questions with yes/no answer options. The interview will be conducted by a study member, either in-person or by telephone.

  4. Acceptability of the intervention as measured by the proportion of participants who are interested in pursuing mindfulness therapies in the future [at the time of hospital discharge, up to 6 months post-intervention]

    This data will be collected via a post-intervention survey and interview. The survey will contain simple questions with yes/no answer options. The interview will be conducted by a study member, either in-person or by telephone.

  5. Participant engagement as measured by the number of mindfulness videos watched by each participant during their hospitalization [at the time of hospital discharge, up to 6 months post-intervention]

  6. Participant engagement as measured by the percentage of videos completed. A video is considered completed if the participant watches more than 85% of the video. [at the time of hospital discharge, up to 6 months post-intervention]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion criteria:
  • Patients with sickle cell disease, any genotype

  • Adult patients at least 18 years of age

  • English speaking

  • Admitted to Clements University Hospital with an acute vaso-occlusive pain crisis

Exclusion criteria:
  • Unable to follow simple instructions

  • Admitted to the intensive care unit

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Texas Southwestern Medical Center Dallas Texas United States 75390

Sponsors and Collaborators

  • University of Texas Southwestern Medical Center

Investigators

  • Principal Investigator: Siayareh Rambally, M.D., University of Texas Southwestern Medical Center

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Siayareh Rambally, Associate Professor, University of Texas Southwestern Medical Center
ClinicalTrials.gov Identifier:
NCT05572294
Other Study ID Numbers:
  • STU-2021-0729
First Posted:
Oct 7, 2022
Last Update Posted:
Nov 18, 2022
Last Verified:
Nov 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Siayareh Rambally, Associate Professor, University of Texas Southwestern Medical Center
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 18, 2022